Posts

Showing posts with the label Refractory Gout Market

Decoding the Refractory Gout Market: Trends, Demand Surge, and Key Player Insights

  Market Overview Global  Refractory Gout Market size  and share is currently valued at USD 1,050.21 million in 2024 and is anticipated to generate an estimated revenue of USD 1,599.24 million by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 4.3% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 - 2034 Refractory gout, also referred to as treatment-resistant gout, occurs when standard urate-lowering therapies such as allopurinol or febuxostat fail to achieve optimal results. Patients with this condition experience persistent inflammation, recurrent gout flares, and deposition of uric acid crystals leading to joint deformities and tophi formation. The rising global prevalence of gout and associated comorbidities has created a pressing need for novel therapeutic approaches targeting this challenging form of the disease. Pharmaceutical companies are investing significantly in t...